Company Encyclopedia
View More
name
BYHEALTH
300146.SZ
Byhealth Co., Ltd, together with its subsidiaries, provides dietary supplements in Mainland China, Hong Kong, Australia, and internationally. The company offers protein powder; collagen; bone health products, such as glucosamine, chondroitin, and calcium tablets; probiotics; capsules; and multivitamins. It sells its products under the By-Health, Jianli, LifeSpace and other brands through retail terminals, including pharmacies, supermarkets, and maternal and child stores, as well as through distributors; and e-commerce platforms, including Tmall, JD.com, Vipshop, Douyin, and Kuaishou. The company also engages in scenic spot tourism management; real estate; trade and investment; trademark management; and OTC approval and outsourcing activities.
255.56 B
300146.SZMarket value -Rank by Market Cap -/-

Financial Score

30/12/2025 Update
C
Personal Care ProductsIndustry
Industry Ranking14/27
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE6.11%C
    • Profit Margin11.49%B
    • Gross Margin68.71%A
  • Growth ScoreD
    • Revenue YoY-18.18%E
    • Net Profit YoY-3.12%C
    • Total Assets YoY3.32%C
    • Net Assets YoY0.25%C
  • Cash ScoreD
    • Cash Flow Margin870.57%B
    • OCF YoY-18.18%E
  • Operating ScoreC
    • Turnover0.44C
  • Debt ScoreA
    • Gearing Ratio18.60%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Hanshow Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025

    Hanshow Technology Co., Ltd. reported its earnings for the nine months ending September 30, 2025. The company experienced a decline in sales, reporting CNY 2,809.06 million, down from CNY 3,157.5 million the previous year. Net income also fell to CNY 314.39 million from CNY 528.47 million year-over-year. Basic and diluted earnings per share from continuing operations decreased to CNY 0.7624, compared to CNY 1.3901 a year ago.

    marketscreener·
    SZ
    301275
    +0.70%
    marketscreener·
    SZ
    301275
    +0.70%

    BYHEALTH released its performance for the first three quarters, with a net profit attributable to the parent company of 907 million yuan, an increase of 4.45%

    According to the Zhitong Finance APP, BYHEALTH released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 4.915 billion yuan, a year-on-year decrease of 14.27%. The net profit attributable to shareholders of the listed company was 907 million yuan, a year-on-year increase of 4.45%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 827 million yuan, a year-on-year increase of 2.44%. The basic earnings per share were 0.53 yuan

    Zhitong·
    SZ
    300146
    -0.58%
    Zhitong·
    SZ
    300146
    -0.58%

    BYHEALTH responds to the "workplace bullying" incident: no evidence found of repeated targeting or malicious treatment by the accused

    On October 16th, BYHEALTH issued a statement in response to employee complaints about workplace bullying at Guangzhou Maiyou. After a comprehensive investigation, no evidence was found of repeated targeting or malicious treatment by the accused, and it could not be classified as workplace bullying. During the investigation, the labor union and labor inspection team also intervened to ensure the objectivity and fairness of the investigation

    Zhitong·
    SZ
    300146
    -0.58%
    Zhitong·
    SZ
    300146
    -0.58%

    Guosheng Securities: BYHEALTH's profitability is expected to continue improving, and it will continue to enhance its e-commerce investment strategy

    Guosheng Securities research report pointed out that BYHEALTH has significantly improved its profitability by optimizing sales expense allocation. It is expected that with a very low base and support from new products, the revenue growth in the second half of 2025 will turn positive. The company will continue to improve its e-commerce investment strategy, increasing investment in core categories, especially on platforms like Douyin, and it is expected that profitability will continue to improve

    Zhitong·
    SZ
    300146
    -0.58%
    Zhitong·
    SZ
    300146
    -0.58%

    BYHEALTH released its performance for the first half of the year, with a net profit attributable to the parent company of 737 million yuan, a decrease of 17.34%

    BYHEALTH released its 2025 semi-annual report, with operating revenue of 3.532 billion yuan, a year-on-year decrease of 23.43%. The net profit attributable to the parent company was 737 million yuan, a year-on-year decline of 17.34%. The net profit excluding non-recurring gains and losses was 693 million yuan, a year-on-year decrease of 16.59%. The main brand "BYHEALTH" generated revenue of 1.888 billion yuan, a year-on-year decline of 28.32%; "Jianliduo" revenue was 411 million yuan, a year-on-year decrease of 30.35%; "lifespace" domestic product revenue was 138 million yuan, a year-on-year decrease of 34.43%; overseas LSG revenue was 534 million yuan, a year-on-year increase of 13.46%

    Zhitong·
    SZ
    300146
    -0.58%
    Zhitong·
    SZ
    300146
    -0.58%
    © 2025 Longbridge｜Disclaimer